MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 207 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $87,000 | -26.9% | 1,213 | 0.0% | 0.02% | -8.7% |
Q1 2022 | $119,000 | +15.5% | 1,213 | 0.0% | 0.02% | +27.8% |
Q4 2021 | $103,000 | 0.0% | 1,213 | -6.0% | 0.02% | 0.0% |
Q3 2021 | $103,000 | -18.3% | 1,291 | 0.0% | 0.02% | -10.0% |
Q2 2021 | $126,000 | -16.6% | 1,291 | 0.0% | 0.02% | -23.1% |
Q1 2021 | $151,000 | +4.9% | 1,291 | 0.0% | 0.03% | +4.0% |
Q4 2020 | $144,000 | -5.9% | 1,291 | 0.0% | 0.02% | -13.8% |
Q3 2020 | $153,000 | +4.8% | 1,291 | 0.0% | 0.03% | +11.5% |
Q2 2020 | $146,000 | +69.8% | 1,291 | 0.0% | 0.03% | +36.8% |
Q1 2020 | $86,000 | -27.1% | 1,291 | 0.0% | 0.02% | -13.6% |
Q4 2019 | $118,000 | +6.3% | 1,291 | 0.0% | 0.02% | 0.0% |
Q3 2019 | $111,000 | +58.6% | 1,291 | +93.8% | 0.02% | +69.2% |
Q2 2019 | $70,000 | -15.7% | 666 | 0.0% | 0.01% | -13.3% |
Q1 2019 | $83,000 | +10.7% | 666 | 0.0% | 0.02% | 0.0% |
Q4 2018 | $75,000 | -47.6% | 666 | 0.0% | 0.02% | -16.7% |
Q3 2018 | $143,000 | +5.9% | 666 | +38.5% | 0.02% | +5.9% |
Q2 2018 | $135,000 | – | 481 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |